Cell cycle, CDKs and cancer: a changing paradigm

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683 · see citing works

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,178 · see citing works

p53, guardian of the genome

Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138 · see citing works

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649 · see citing works

p21 is a universal inhibitor of cyclin kinases

Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691 · see citing works

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · see citing works

Patterns of somatic mutation in human cancer genomes

Greenman, C. D., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G. R., Davies, H. R., Teague, J. W., Butler, A. P., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,062 · see citing works

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · see citing works

Cell-cycle checkpoints and cancer

Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836 · see citing works

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · see citing works

The spindle-assembly checkpoint in space and time

Musacchio, A., & Salmon, E. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2163 · Cited by 2,227 · see citing works

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,208 · see citing works

BRAFE600-associated senescence-like cell cycle arrest of human naevi

Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · see citing works

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

Polyák, K., Lee, M.-H., Erdjument‐Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118 · see citing works

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009 · see citing works

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993 · see citing works

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · see citing works

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Preprint

Polyak, K., Kato, J., Solomon, M., Sherr, C., Massagué, J., Roberts, J., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,949 · see citing works

An Oncogene-Induced DNA Damage Model for Cancer Development

Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851 · see citing works

Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Kuerbitz, S. J., Plunkett, B., Walsh, W., & Kastan, M. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7491 · Cited by 1,837 · see citing works

Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication

Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · see citing works

ATR: an essential regulator of genome integrity

Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798 · see citing works

Genetic Control of the Cell Division Cycle in Yeast

Hartwell, L. H., Culotti, J. G., Pringle, J. R., & Reid, B. J. (1974) · Science · doi:10.1126/science.183.4120.46 · Cited by 1,567 · see citing works

Cyclin: A protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division

Evans, T., Rosenthal, E. T., Youngblom, J., Distel, D. L., & Hunt, T. (1983) · Cell · doi:10.1016/0092-8674(83)90420-8 · Cited by 1,516 · see citing works

Mutations of mitotic checkpoint genes in human cancers

Cahill, D. P., Christoph Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,485 · see citing works

Senescence in premalignant tumours

Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482 · see citing works

To cycle or not to cycle: a critical decision in cancer

Malumbres, M., & Barbacid, M. (2001) · Nature reviews. Cancer · doi:10.1038/35106065 · Cited by 1,475 · see citing works

Ubiquitin ligases: cell-cycle control and cancer

Nakayama, K. I., & Nakayama, K. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1881 · Cited by 1,441 · see citing works

Hematopoietic Stem Cell Quiescence Maintained by p21 ^cip1/waf1

Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339 · see citing works

The anaphase promoting complex/cyclosome: a machine designed to destroy

Peters, J.-M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1988 · Cited by 1,315 · see citing works

Mammalian cyclin-dependent kinases

Malumbres, M., & Barbacid, M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.09.005 · Cited by 1,294 · see citing works

Oncogene-induced senescence as an initial barrier in lymphoma development

Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220 · see citing works

G1 cell-cycle control and cancer

Massagué, J. (2004) · Nature · doi:10.1038/nature03094 · Cited by 1,217 · see citing works

A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers

Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N., & Szállási, Z. (2006) · Nature Genetics · doi:10.1038/ng1861 · Cited by 1,199 · see citing works

On the road to cancer: aneuploidy and the mitotic checkpoint

Kops, G. J. P. L., Weaver, B. A. A., & Cleveland, D. W. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1714 · Cited by 1,188 · see citing works

Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle

Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,169 · see citing works

Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2

Lee, M. G., & Nurse, P. (1987) · Nature · doi:10.1038/327031a0 · Cited by 1,163 · see citing works

Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a

Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106 · see citing works

Cdk1 is sufficient to drive the mammalian cell cycle

Santamarı́a, D., Barrière, C., Cerqueira, A., Hunt, S. L., Tardy, C., Newton, K., Cáceres, J. F., Dubus, P. R., Malumbres, M., & Barbacid, M. (2007) · Nature · doi:10.1038/nature06046 · Cited by 1,096 · see citing works

Distinct Roles for Cyclin-Dependent Kinases in Cell Cycle Control

van den Heuvel, S., & Harlow, E. (1993) · Science · doi:10.1126/science.8266103 · Cited by 1,092 · see citing works

Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes

Lundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,077 · see citing works

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1

Harbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057 · see citing works

Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment

Shapiro, G. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7689 · Cited by 1,036 · see citing works

Single-strand break repair and genetic disease

Caldecott, K. W. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2380 · Cited by 1,034 · see citing works

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas

Loda, M. F., Cukor, B., Tam, S. W., Lavin, P. T., Fiorentinc, M., Draetta, G. F., Jessup, J. M., & Pagano, M. (1997) · Nature Medicine · doi:10.1038/nm0297-231 · Cited by 1,031 · see citing works

p16INK4a induces an age-dependent decline in islet regenerative potential

Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · see citing works

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle

Buchkovich, K., Duffy, L. A., & Harlow, E. (1989) · Cell · doi:10.1016/0092-8674(89)90508-4 · Cited by 995 · see citing works

D-type cyclins

Sherr, C. J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89005-2 · Cited by 980 · see citing works

Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing

Molofsky, A. V., Slutsky, S. G., Joseph, N. M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N. E., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature05091 · Cited by 972 · see citing works

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.Preprint

Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., & Elledge, S. J. (1995) · Genes & Development · doi:10.1101/gad.9.6.650 · Cited by 952 · see citing works

Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation

Chen, P.-L., Scully, P., Shew, J.-Y., Wang, J. Y. J., & Lee, W.-H. (1989) · Cell · doi:10.1016/0092-8674(89)90517-5 · Cited by 952 · see citing works

Specific protection against breast cancers by cyclin D1 ablation

Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934 · see citing works

Regulation of the specific DNA binding function of p53

Hupp, T. R., Meek, D. W., Midgley, C., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 910 · see citing works

Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer

Lavin, M. F. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2514 · Cited by 901 · see citing works

Identification and properties of an atypical catalytic subunit (p34PSK-J3/Cdk4) for mammalian D type G1 cyclins

Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897 · see citing works

The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element

DeCaprio, J. A., Ludlow, J. W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica-Worms, H., Huang, C.-M., & Livingston, D. M. (1989) · Cell · doi:10.1016/0092-8674(89)90507-2 · Cited by 897 · see citing works

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.Preprint

Lee, M., Reynisdóttir, I., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.6.639 · Cited by 889 · see citing works

Genetic control of cell size at cell division in yeast

Nurse, P. (1975) · Nature · doi:10.1038/256547a0 · Cited by 868 · see citing works

Targeting polo-like kinase 1 for cancer therapy

Strebhardt, K., & Ullrich, A. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1841 · Cited by 843 · see citing works

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer

Catzavelos, C., Bhattacharya, N., Ung, Y., Wilson, J. A., Roncari, L., Sandhu, C., Shaw, P. H., Yeger, H., Morava‐Protzner, I., Kapusta, L. R., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-227 · Cited by 824 · see citing works

Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast

Lew, D. J., Dulić, V., & Reed, S. I. (1991) · Cell · doi:10.1016/0092-8674(91)90042-w · Cited by 820 · see citing works

Genome instability: a mechanistic view of its causes and consequences

Aguilera, A., & Gómez‐González, B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2268 · Cited by 806 · see citing works

Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice

Ortega, S., Priéto, I., Odajima, J., Martín, A. L., Dubus, P. R., Sotillo, R., Barbero, J. L., Malumbres, M., & Barbacid, M. (2003) · Nature Genetics · doi:10.1038/ng1232 · Cited by 798 · see citing works

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

Malumbres, M., Sotillo, R., Santamarı́a, D., Galán, J., Cerezo, A., Ortega, S., Dubus, P., & Barbacid, M. (2004) · Cell · doi:10.1016/j.cell.2004.08.002 · Cited by 793 · see citing works

Zur Frage der Entstehung maligner Tumoren

Boveri, T. (1914) · Cited by 789 · see citing works

Cyclin D-dependent kinases, INK4 inhibitors and cancer

Ortega, S., Malumbres, M., & Barbacid, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00037-9 · Cited by 774 · see citing works

Checking on DNA damage in S phase

Bartek, J., Lukas, C., & Lukas, J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1493 · Cited by 758 · see citing works

BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice

Baker, D. J., Jeganathan, K. B., Cameron, J. D., Thompson, M., Juneja, S., Kopecka, A., Kumar, R., Jenkins, R. B., de Groen, P. C., Roche, P., et al. (2004) · Nature Genetics · doi:10.1038/ng1382 · Cited by 731 · see citing works

Aneuploidy Acts Both Oncogenically and as a Tumor Suppressor

Weaver, B. A. A., Silk, A. D., Montagna, C., Verdier-Pinard, P., & Cleveland, D. W. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.003 · Cited by 729 · see citing works

MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells

Michel, L. S., Liberal, V., Chatterjee, A., Kirchwegger, R., Pasche, B., Gerald, W. L., Dobles, M., Sorger, P. K., Murty, V. V. V. S., & Benezra, R. (2001) · Nature · doi:10.1038/35053094 · Cited by 725 · see citing works

Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation

Kato, J., Matsuoka, M., Polyák, K., Massagué, J., & Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90257-7 · Cited by 720 · see citing works

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.Preprint

Guan, K., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C., Matera, A. G., & Xiong, Y. (1994) · Genes & Development · doi:10.1101/gad.8.24.2939 · Cited by 707 · see citing works

Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia

Rane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P., & Barbacid, M. (1999) · Nature Genetics · doi:10.1038/8751 · Cited by 700 · see citing works

Human D-type cyclin

Xiong, Y., Connolly, T., Futcher, B., & Beach, D. (1991) · Cell · doi:10.1016/0092-8674(91)90100-d · Cited by 687 · see citing works

Aurora-kinase inhibitors as anticancer agents

Keen, N., & Taylor, S. S. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1502 · Cited by 680 · see citing works

CDK8 is a colorectal cancer oncogene that regulates β-catenin activity

Firestein, R., Bass, A. J., Kim, S. Y., Dunn, I. F., Silver, S. J., Guney, I., Freed, E., Ligon, A. H., Vena, N., Ogino, S., et al. (2008) · Nature · doi:10.1038/nature07179 · Cited by 678 · see citing works

Cdk2 Knockout Mice Are Viable

Berthet, C., Aleem, E. A., Coppola, V., Tessarollo, L., & Kaldis, P. (2003) · Current Biology · doi:10.1016/j.cub.2003.09.024 · Cited by 665 · see citing works

Cyclin E Ablation in the Mouse

Geng, Y., Yu, Q., Sicińska, E., Das, M., Schneider, J. E., Bhattacharya, S., Rideout, W. M., Bronson, R. T., Gardner, H., & Siciński, P. (2003) · Cell · doi:10.1016/s0092-8674(03)00645-7 · Cited by 663 · see citing works

Mouse development and cell proliferation in the absence of D-cyclins

Kozar, K., Ciemerych, M. A., Rebel, V. I., Shigematsu, H., Zagozdzon, A., Sicinska, E., Geng, Y., Yu, Q., Bhattacharya, S., Bronson, R. T., et al. (2004) · Cell · doi:10.1016/j.cell.2004.07.025 · Cited by 647 · see citing works

Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B

Hanks, S., Coleman, K., Reid, S., Plaja, A., Firth, H., Fitzpatrick, D., Kidd, A., Méhes, K., Nash, R., Robin, N. H., et al. (2004) · Nature Genetics · doi:10.1038/ng1449 · Cited by 627 · see citing works

Mad2 Overexpression Promotes Aneuploidy and Tumorigenesis in Mice

Sotillo, R., Hernando, E., Díaz-Rodríguez, E., Teruya-Feldstein, J., Cordón-Cardo, C., Lowe, S. W., & Benezra, R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.019 · Cited by 612 · see citing works

Cyclin-dependent kinases and cell-cycle transitions: does one fit all?

Hochegger, H., Takeda, S., & Hunt, T. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2510 · Cited by 599 · see citing works

Identification of a Human Mitotic Checkpoint Gene: hsMAD2

Li, Y., & Benezra, R. (1996) · Science · doi:10.1126/science.274.5285.246 · Cited by 597 · see citing works

Wild-type p53 activates transcription in vitro

Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., & Prives, C. (1992) · Nature · doi:10.1038/358083a0 · Cited by 579 · see citing works

Genetic Control of the Cell-Division Cycle in Yeast, I. Detection of Mutants

Hartwell, L. H., Culotti, J. G., & Reid, B. J. (1970) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.66.2.352 · Cited by 576 · see citing works

Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.Preprint

Xiong, Y., Zhang, H., & Beach, D. (1993) · Genes & Development · doi:10.1101/gad.7.8.1572 · Cited by 507 · see citing works

Multiple levels of cyclin specificity in cell-cycle control

Bloom, J., & Cross, F. R. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2105 · Cited by 504 · see citing works

Polo on the Rise—from Mitotic Entry to Cytokinesis with Plk1

Petronczki, M. P., Lénárt, P., & Peters, J. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.04.014 · Cited by 485 · see citing works

Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells

Carlson, M. E., Hsu, M., & Conboy, I. M. (2008) · Nature · doi:10.1038/nature07034 · Cited by 483 · see citing works

CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair

Esashi, F., Christ, N., Gannon, J., Liu, Y., Hunt, T., Jasin, M., & West, S. C. (2005) · Nature · doi:10.1038/nature03404 · Cited by 473 · see citing works

Proliferation of cancer cells despite CDK2 inhibition

Tetsu, O., & McCormick, F. P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00053-9 · Cited by 467 · see citing works

CDK targets Sae2 to control DNA-end resection and homologous recombination

Huertas, P., Cortés‐Ledesma, F., Sartori, A. A., Aguilera, A., & Jackson, S. P. (2008) · Nature · doi:10.1038/nature07215 · Cited by 456 · see citing works

p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity

Kippin, T. E., Martens, D. J., & van der Kooy, D. (2005) · Genes & Development · doi:10.1101/gad.1272305 · Cited by 442 · see citing works

Requirement for CDK4 kinase function in breast cancer

Yu, Q., Sicinska, E., Geng, Y., Ahnström, M., Zagozdzon, A., Kong, Y., Gardner, H., Kiyokawa, H., Harris, L. N., Stål, O., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.012 · Cited by 429 · see citing works

Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation

Choudhury, A. R., Ju, Z., Djojosubroto, M. W., Schienke, A., Lechel, A., Schaetzlein, S., Jiang, H., Stepczynska, A., Wang, C., Buer, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1937 · Cited by 426 · see citing works

NFATc1 Balances Quiescence and Proliferation of Skin Stem Cells

Horsley, V., Aliprantis, A. O., Polak, L., Glimcher, L. H., & Fuchs, E. (2008) · Cell · doi:10.1016/j.cell.2007.11.047 · Cited by 424 · see citing works

Targeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27 ^Kip1 Activity

Tsutsui, T., Hesabi, B., Moons, D. S., Pandolfi, P. P., Hansel, K. S., Koff, A., & Kiyokawa, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7011 · Cited by 395 · see citing works

Cdc2–cyclin E complexes regulate the G1/S phase transition

Aleem, E. A., Kiyokawa, H., & Kaldis, P. (2005) · Nature Cell Biology · doi:10.1038/ncb1284 · Cited by 383 · see citing works

Secrets of a double agent: CDK7 in cell-cycle control and transcription

Fisher, R. P. (2005) · Journal of Cell Science · doi:10.1242/jcs.02718 · Cited by 365 · see citing works

Finishing mitosis, one step at a time

Sullivan, M., & Morgan, D. O. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2276 · Cited by 359 · see citing works

Genomic stability and tumour suppression by the APC/C cofactor Cdh1

García-Higuera, I., Manchado, E., Dubus, P. R., Cañamero, M., Méndez, J., Moreno, S., & Malumbres, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1742 · Cited by 357 · see citing works

Zur Frage der Entstehung maligner Tumoren

Ribbert, H., & Bally, W. (1914) · Die Naturwissenschaften · doi:10.1007/bf01497322 · Cited by 343 · see citing works

Cell cycle kinases in cancer

Malumbres, M., & Barbacid, M. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.008 · Cited by 338 · see citing works

Rescue of Cyclin D1 Deficiency by Knockin Cyclin E

Geng, Y., Whoriskey, W. J., Park, M. Y., Bronson, R. T., Medema, R. H., Li, T., Weinberg, R. A., & Siciński, P. (1999) · Cell · doi:10.1016/s0092-8674(00)80788-6 · Cited by 336 · see citing works

Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis

Landis, M. W., Pawlyk, B. S., Li, T., Sicinski, P., & Hinds, P. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.019 · Cited by 329 · see citing works

Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts.

Pagano, M., Pepperkok, R., Lukáš, J., Baldin, V., Ansorge, W., Bártek, J., & Draetta, G. F. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.121.1.101 · Cited by 322 · see citing works

Cyclin C/Cdk3 Promotes Rb-Dependent G0 Exit

Ren, S., & Rollins, B. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00300-9 · Cited by 316 · see citing works

Oncogenes and tumour suppressors take on centrosomes

Fukasawa, K. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2249 · Cited by 313 · see citing works

E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8

Morris, E. J., Ji, J., Yang, F., Stefano, L. D., Herr, A., Moon, N. S., Kwon, E. J., Haigis, K. M., Näär, A. M., & Dyson, N. J. (2008) · Nature · doi:10.1038/nature07310 · Cited by 297 · see citing works

Slippage of Mitotic Arrest and Enhanced Tumor Development in Mice with BubR1 Haploinsufficiency

Dai, W. H., Wang, Q., Liu, T., Swamy, M. V., Fang, Y., Xie, S., Mahmood, R., Yang, Y., Xu, M., & Rao, C. V. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3119 · Cited by 291 · see citing works

Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero

Brandeis, M., Rosewell, I. R., Carrington, M., Crompton, T., Jacobs, M. A., Kirk, J. A., Gannon, J., & Hunt, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4344 · Cited by 290 · see citing works

CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin?

Antoni, L., Sodha, N., Collins, I., & Garrett, M. D. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2251 · Cited by 287 · see citing works

Delayed early embryonic lethality following disruption of the murine cyclin A2 gene

Murphy, M., Stinnakre, M., Sénamaud‐Beaufort, C., Winston, N. J., Sweeney, C., Kubelka, M., Carrington, M., Bréchot, C., & Sobczak‐Thépot, J. (1997) · Nature Genetics · doi:10.1038/ng0197-83 · Cited by 279 · see citing works

Requirements for Cdk7 in the Assembly of Cdk1/Cyclin B and Activation of Cdk2 Revealed by Chemical Genetics in Human Cells

Larochelle, S., Merrick, K. A., Terret, M., Wohlbold, L., Barboza, N. M., Zhang, C., Shokat, K. M., Jallepalli, P. V., & Fisher, R. P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.003 · Cited by 271 · see citing works

In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C

Yuan, Y., Shen, H., Franklin, D. S., Scadden, D. T., & Cheng, T. (2004) · Nature Cell Biology · doi:10.1038/ncb1126 · Cited by 269 · see citing works

Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells

Parisi, T., Beck, A. R., Rougier, N., McNeil, T., Lucian, L. A., Werb, Z., & Amati, B. B. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg482 · Cited by 264 · see citing works

CDK inhibitors in cancer therapy: what is next?

Malumbres, M., Pevarello, P., Barbacid, M., & Bischoff, J. R. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.012 · Cited by 240 · see citing works

Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis

Jeganathan, K. B., Malureanu, L. A., Baker, D., Abraham, S., & van Deursen, J. (2007) · Journal of Cell Biology · doi:10.1083/jcb.200706015 · Cited by 238 · see citing works

Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer

Iorns, E. J., Turner, N. C., Elliott, R. J. R., Syed, N., Garrone, O., Gasco, M., Tutt, A. N. J., Crook, T., Lord, C. J., & Ashworth, A. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.001 · Cited by 230 · see citing works

Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1

Martín, A. L., Odajima, J., Hunt, S. L., Dubus, P. R., Ortega, S., Malumbres, M., & Barbacid, M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.006 · Cited by 223 · see citing works

A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy

de Castro, I. P., de Cárcer, G., & Malumbres, M. (2006) · Carcinogenesis · doi:10.1093/carcin/bgm019 · Cited by 215 · see citing works

14-3-3σ controls mitotic translation to facilitate cytokinesis

Wilker, E., van Vugt, M. V., Artim, S. C., Huang, P. H., Petersen, C. P., Reinhardt, H., Feng, Y., Sharp, P. A., Sonenberg, N., White, F. M., et al. (2007) · Nature · doi:10.1038/nature05584 · Cited by 209 · see citing works

Wide spectrum of tumors in knock‐in mice carrying a Cdk4 protein insensitive to INK4 inhibitors

Sotillo, R., Dubus, P., Martn, J., de la Cueva, E., Ortega, S., Malumbres, M., & Barbacid, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6637 · Cited by 208 · see citing works

Discovery of an oncogenic activity in p27 Kip1 that causes stem cell expansion and a multiple tumor phenotypePreprint

Besson, A., Hwang, H. C., Cicero, S. A., Donovan, S. L., Gurian-West, M., Johnson, D. A., Clurman, B. E., Dyer, M. A., & Roberts, J. M. (2007) · Genes & Development · doi:10.1101/gad.1556607 · Cited by 208 · see citing works

Aneuploidy: Instigator and Inhibitor of Tumorigenesis

Weaver, B. A. A., & Cleveland, D. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2266 · Cited by 195 · see citing works

The reversibility of mitotic exit in vertebrate cells

Potapova, T., Daum, J. R., Pittman, B. D., Hudson, J. R., Jones, T. N., Satinover, D. L., Stukenberg, P. T., & Gorbsky, G. J. (2006) · Nature · doi:10.1038/nature04652 · Cited by 190 · see citing works

Role of CDK/cyclin complexes in transcription and RNA splicing

Loyer, P., Trembley, J. H., Katona, R. L., Kidd, V. J., & Lahti, J. M. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.02.005 · Cited by 188 · see citing works

Kinase-independent function of cyclin E

Geng, Y., Lee, Y.-M., Welcker, M., Swanger, J., Zagozdzon, A., Winer, J. D., Roberts, J. M., Kaldis, P., Clurman, B. E., & Sicinski, P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.11.029 · Cited by 187 · see citing works

Cdc20 and Cks Direct the Spindle Checkpoint-Independent Destruction of Cyclin A

Wolthuis, R. M. F., Clay-Farrace, L., van Zon, W., Yekezare, M., Koop, L., Ogink, J., Medema, R. H., & Pines, J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.027 · Cited by 176 · see citing works

An essential role for Cdk1 in S phase control is revealed via chemical genetics in vertebrate cells

Hochegger, H., Dejsuphong, D., Sonoda, E., Saberi, A., Rajendra, E., Kirk, J. A., Hunt, T., & Takeda, S. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200702034 · Cited by 170 · see citing works

Germ Line Transmission of the <i>Cdk4</i>^R24C Mutation Facilitates Tumorigenesis and Escape from Cellular Senescence

Rane, S. G., Cosenza, S. C., Mettus, R. V., & Reddy, E. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.644-656.2002 · Cited by 167 · see citing works

Pho85, a multifunctional cyclin‐dependent protein kinase in budding yeast

Huang, D., Friesen, H., & Andrews, B. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05914.x · Cited by 165 · see citing works

Invasive melanoma in Cdk4-targeted mice

Sotillo, R., García, J. F., Ortega, S., Martín‐Broto, J., Dubus, P. R., Barbacid, M., & Malumbres, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241338598 · Cited by 164 · see citing works

Early mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C

Hayes, M. J., Kimata, Y., Wattam, S. L., Lindon, C., Mao, G., Yamano, H., & Fry, A. M. (2006) · Nature Cell Biology · doi:10.1038/ncb1410 · Cited by 160 · see citing works

The adaptor protein of the anaphase promoting complex Cdh1 is essential in maintaining replicative lifespan and in learning and memory

Li, M., Shin, Y.-H., Hou, L., Huang, X., Wei, Z., Klann, E., & Zhang, P. (2008) · Nature Cell Biology · doi:10.1038/ncb1768 · Cited by 156 · see citing works

Combined Loss of Cdk2 and Cdk4 Results in Embryonic Lethality and Rb Hypophosphorylation

Berthet, C., Klarmann, K. D., Hilton, M. B., Suh, H. C., Keller, J. R., Kiyokawa, H., & Kaldis, P. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.004 · Cited by 152 · see citing works

Cell cycle in mouse development

Ciemerych, M. A., & Siciński, P. (2005) · Oncogene · doi:10.1038/sj.onc.1208608 · Cited by 150 · see citing works

Identification and Characterization of the CDK12/Cyclin L1 Complex Involved in Alternative Splicing Regulation

Chen, H.-H., Wang, Y.-C., & Fann, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2736-2745.2006 · Cited by 144 · see citing works

Cdk-counteracting phosphatases unlock mitotic exit

Queralt, E., & Uhlmann, F. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.09.003 · Cited by 143 · see citing works

Bub1 Maintains Centromeric Cohesion by Activation of the Spindle Checkpoint

Perera, D., Tilston, V., Hopwood, J. A., Barchi, M., Boot-Handford, R., & Taylor, S. S. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.08.008 · Cited by 140 · see citing works

Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability

Mantel, C., Guo, Y., Lee, M. R., Kim, M.-K., Han, M., Shibayama, H., Fukuda, S., Yöder, M. C., Pelus, L. M., Kim, K.-S., et al. (2007) · Blood · doi:10.1182/blood-2006-10-054247 · Cited by 136 · see citing works

The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation

Petretti, C., Savoian, M. S., Montembault, É., Glover, D. M., Prigent, C., & Giet, R. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400639 · Cited by 134 · see citing works

ras-Induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation

Lü, X., Park, S. H., Thompson, T. C., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90541-j · Cited by 132 · see citing works

Polo and Aurora kinases — lessons derived from chemical biology

Taylor, S. S., & Peters, J. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.11.008 · Cited by 131 · see citing works

Hematopoietic stem cell exhaustion impacted by p18INK4C and p21Cip1/Waf1 in opposite manners

Yu, H., Yuan, Y., Shen, H., & Cheng, T. (2006) · Blood · doi:10.1182/blood-2005-02-0685 · Cited by 127 · see citing works

Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity

Maestre, C., Delgado‐Esteban, M., Sánchez, J. C. G., Bolaños, J. P., & Almeida, Á. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.195 · Cited by 126 · see citing works

Mice thrive without Cdk4 and Cdk2

Barrière, C., Santamarı́a, D., Cerqueira, A., Galán, J., Martín, A. L., Ortega, S., Malumbres, M., Dubus, P. R., & Barbacid, M. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.03.001 · Cited by 125 · see citing works

Genetic rescue of Cdk4 null mice restores pancreatic β-cell proliferation but not homeostatic cell number

Martín, J., Hunt, S. L., Dubus, P., Sotillo, R., Néhmé-Pélluard, F., Magnuson, M. A., Parlow, A. F., Malumbres, M., Ortega, S., & Barbacid, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206506 · Cited by 122 · see citing works

The ubiquitin ligase APCCdh1 is required to maintain genome integrity in primary human cells

Engelbert, D., Schnerch, D., Baumgarten, A., & Wäsch, R. (2007) · Oncogene · doi:10.1038/sj.onc.1210703 · Cited by 113 · see citing works

Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons

Zhang, J., Cicero, S. A., Wang, L., Romito-DiGiacomo, R. R., Yang, Y., & Herrup, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711355105 · Cited by 113 · see citing works

Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells

Walkley, C. R., Fero, M. L., Chien, W., Purton, L. E., & McArthur, G. A. (2005) · Nature Cell Biology · doi:10.1038/ncb1214 · Cited by 112 · see citing works

A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene

Ye, X., Zhu, C., & Harper, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1682 · Cited by 105 · see citing works

Cyclin-Dependent Kinase 4 Expression Is Essential for Neu-Induced Breast Tumorigenesis

Reddy, H. K. D. L., Mettus, R. V., Rane, S. G., Graña, X., Litvin, J., & Reddy, E. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2639 · Cited by 105 · see citing works

Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication

Duensing, A. U., Liu, Y., Tseng, M., Malumbres, M., Barbacid, M., & Duensing, S. M. (2005) · Oncogene · doi:10.1038/sj.onc.1209310 · Cited by 103 · see citing works

p21 ^Cip1 restricts neuronal proliferation in the subgranular zone of the dentate gyrus of the hippocampus

Pechnick, R. N., Zonis, S., Wawrowsky, K., Pourmorady, J., & Chesnokova, V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711030105 · Cited by 103 · see citing works

Lack of Cyclin-Dependent Kinase 4 Inhibits c- myc Tumorigenic Activities in Epithelial Tissues

de Marval, P. L. M., Macias, E., Rounbehler, R. J., Siciński, P., Kiyokawa, H., Johnson, D. G., Conti, C. J., & Rodríguez‐Puebla, M. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7538-7547.2004 · Cited by 100 · see citing works

Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant mice

Mettus, R. V., & Rane, S. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206888 · Cited by 97 · see citing works

Is Cyclin D1-CDK4 kinase a bona fide cancer target?

Malumbres, M., & Barbacid, M. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.026 · Cited by 96 · see citing works

CDK11p58 is required for the maintenance of sister chromatid cohesion

Hu, D., Valentine, M. B., Kidd, V. J., & Lahti, J. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.007963 · Cited by 92 · see citing works

Cdk2 is critical for proliferation and self-renewal of neural progenitor cells in the adult subventricular zone

Jablonska, B., Aguirre, A. A., Vandenbosch, R., Belachew, S. M., Berthet, C., Kaldis, P., & Gallo, V. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200702031 · Cited by 92 · see citing works

Cdk11 is a RanGTP-dependent microtubule stabilization factor that regulates spindle assembly rate

Yokoyama, H., Gruß, O. J., Rybina, S., Caudron‐Herger, M., Schelder, M., Wilm, M. S., Mattaj, I. W., & Karsenti, E. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200706189 · Cited by 89 · see citing works

Control of G2 delay by the RAD9 gene of Saccharomyces cerevisiae

Weinert, T. A., & Hartwell, L. H. (1989) · Journal of Cell Science · doi:10.1242/jcs.1989.supplement_12.12 · Cited by 87 · see citing works

Failure To Proliferate and Mitotic Arrest of CDK11p110/p58-Null Mutant Mice at the Blastocyst Stage of Embryonic Cell Development

Li, T., Inoue, A., Lahti, J. M., & Kidd, V. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3188-3197.2004 · Cited by 86 · see citing works

CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing

Chen, H.-H., Wong, Y., Genevière, A., & Fann, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.049 · Cited by 83 · see citing works

Genetic substitution of Cdk1 by Cdk2 leads to embryonic lethality and loss of meiotic function of Cdk2

Ande, S., Berthet, C., Lopez-Molina, J., Coppola, V., Tessarollo, L., & Kaldis, P. (2008) · Development · doi:10.1242/dev.024919 · Cited by 79 · see citing works

CDK activation by non-cyclin proteins

Nebreda, Á. R. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.01.001 · Cited by 75 · see citing works

Cdk4 Is Indispensable for Postnatal Proliferation of the Anterior Pituitary

Jirawatnotai, S., Aziyu, A., Osmundson, E. C., Moons, D. S., Zou, X., Kineman, R. D., & Kiyokawa, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409080200 · Cited by 73 · see citing works

Pituitary Hypoplasia and Lactotroph Dysfunction in Mice Deficient for Cyclin-Dependent Kinase-4

Moons, D. S., Jirawatnotai, S., Parlow, A. F., Gibori, G., Kineman, R. D., & Kiyokawa, H. (2002) · Endocrinology · doi:10.1210/endo.143.8.8956 · Cited by 71 · see citing works

Dual role of CDKs in DNA repair: To be, or not to be

Yata, K., & Esashi, F. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.002 · Cited by 58 · see citing works

Emerging cancer therapeutic opportunities by inhibiting mitotic kinases

de Castro, I. P., de Cárcer, G., Montoya, G., & Malumbres, M. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.013 · Cited by 57 · see citing works

Cooperation between Cdk4 and p27kip1 in Tumor Development: A Preclinical Model to Evaluate Cell Cycle Inhibitors with Therapeutic Activity

Sotillo, R., Renner, O., Dubus, P. R., Ruı́z-Cabello, J., Martín‐Caballero, J., Barbacid, M., Carnero, A., & Malumbres, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4195 · Cited by 53 · see citing works

Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells

Hanashiro, K., Kanai, M., Geng, Y., Siciński, P., & Fukasawa, K. (2008) · Oncogene · doi:10.1038/onc.2008.161 · Cited by 51 · see citing works

p18 Ink4c Collaborates with Men1 to Constrain Lung Stem Cell Expansion and Suppress Non–Small-Cell Lung Cancers

Pei, X., Bai, F., Smith, M. D., & Xiong, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4517 · Cited by 45 · see citing works

Loss of the tumor suppressor p15Ink4b enhances myeloid progenitor formation from common myeloid progenitors

Rosu‐Myles, M., Taylor, B. J., & Wolff, L. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.11.005 · Cited by 35 · see citing works

Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice

Chandramouli, A., Shi, J., Feng, Y., Holubec, H., Shañas, R., Bhattacharyya, A. K., Zheng, W., & Nelson, M. A. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm066 · Cited by 25 · see citing works

The wages of CIN

Yuen, K. W. Y., & Desai, A. B. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200801030 · Cited by 15 · see citing works

Synchronicity: policing multiple aspects of gene expression by Ctk1: Figure 1.Preprint

Hampsey, M., & Kinzy, T. G. (2007) · Genes & Development · doi:10.1101/gad.1564807 · Cited by 6 · see citing works

p21 in cancer: Intricate networks and multiple activities

Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712 · see citing works

Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay

Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261 · see citing works

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

Finn, R. S., Crown, J. P., Lang, I., Boer, K., Bondarenko, I. M., Kulyk, S. O., Ettl, J., Patel, R., Pinter, T., Schmidt, M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71159-3 · Cited by 1,900 · see citing works

Programmed Cell Death in Animal Development and Disease

Fuchs, Y., & Steller, H. (2011) · Cell · doi:10.1016/j.cell.2011.10.033 · Cited by 1,915 · see citing works

Cell cycle proteins as promising targets in cancer therapy

Otto, T., & Siciński, P. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2016.138 · Cited by 1,873 · see citing works

Iron and cancer: more ore to be mined

Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621 · see citing works

Cyclin-dependent kinases

Malumbres, M. (2014) · Genome biology · doi:10.1186/gb4184 · Cited by 1,683 · see citing works

Cdks, cyclins and CKIs: roles beyond cell cycle regulation

Lim, S., & Kaldis, P. (2013) · Development · doi:10.1242/dev.091744 · Cited by 1,483 · see citing works

Cell cycle control in cancer

Matthews, H. K., Bertoli, C., & de Bruin, R. A. M. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00404-3 · Cited by 1,506 · see citing works

Cyclin D as a therapeutic target in cancer

Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370 · see citing works

Treating cancer with selective CDK4/6 inhibitors

O'Leary, B., Finn, R. S., & Turner, N. C. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.26 · Cited by 1,137 · see citing works

Emerging roles of E2Fs in cancer: an exit from cell cycle control

Chen, H., Tsai, S., & Leone, G. W. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2696 · Cited by 1,019 · see citing works

Circular RNAs function as ceRNAs to regulate and control human cancer progression

Zhong, Y., Du, Y., Yang, X. F., Mo, Y., Fan, C., Xiong, F., Ren, D., Ye, X., Li, C., Wang, Y., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0827-8 · Cited by 1,008 · see citing works

Electrochemical Methods for the Analysis of Clinically Relevant Biomolecules

Labib, M., Sargent, E. H., & Kelley, S. O. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00220 · Cited by 981 · see citing works

Targeting CDK4 and CDK6: From Discovery to Therapy

Sherr, C. J., Beach, D., & Shapiro, G. I. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0894 · Cited by 936 · see citing works

Cell cycle kinases as therapeutic targets for cancer

Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 906 · see citing works

Exploiting senescence for the treatment of cancer

Wang, L., Lankhorst, L., & Bernards, R. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00450-9 · Cited by 867 · see citing works

Revisiting the hallmarks of cancer.

Fouad, Y. A., & Aanei, C. M. (2017) · Europe PMC (PubMed Central) · Cited by 873 · see citing works

Targeting oncogenic Myc as a strategy for cancer treatment

Chen, H., Liu, H., & Qing, G. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0008-7 · Cited by 806 · see citing works

Control of protein stability by post-translational modifications

Lee, J. M., Hammarén, H. M., Savitski, M. M., & Baek, S. H. (2023) · Nature Communications · doi:10.1038/s41467-023-35795-8 · Cited by 822 · see citing works

Sustained proliferation in cancer: Mechanisms and novel therapeutic targets

Feitelson, M. A., Arzumanyan, A. L., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J. A., Marino, M., Martínez‐Chantar, M. L., Nawroth, R., Sánchez-Garcı́a, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 783 · see citing works

Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors

Patnaik, A., Rosen, L. S., Tolaney, S. M., Tolcher, A. W., Goldman, J. W., Gandhi, L., Papadopoulos, K. P., Beeram, M., Rasco, D. W., Hilton, J. F., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0095 · Cited by 743 · see citing works

Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer

Herrera-Abreu, M. T., Palafox, M., Asghar, U. S., Rivas, M. A., Cutts, R. J., García-Murillas, I., Pearson, A., Guzmán, M., Rodríguez, O., Grueso, J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0728 · Cited by 768 · see citing works

MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

Dickler, M. N., Tolaney, S. M., Rugo, H. S., Cortés, J., Dieras, V. C., Patt, D. A., Wildiers, H. P. M. W., Hudis, C. A., O’Shaughnessy, J., Zamora, E., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0754 · Cited by 683 · see citing works

The cell cycle and cancer

Williams, G. H., & Stoeber, K. (2011) · The Journal of Pathology · doi:10.1002/path.3022 · Cited by 664 · see citing works

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

Barretina, J., Taylor, B. S., Banerji, S., Ramos, A. H., Lagos-Quintana, M., DeCarolis, P. L., Shah, K., Socci, N. D., Weir, B. A., Ho, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.619 · Cited by 735 · see citing works

Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study

Roychowdhury, S., Iyer, M. K., Robinson, D. R., Lonigro, R. J., Wu, Y.-M., Cao, X., Sundaram, S. K., Sam, L. T., Balbin, O. A., Quist, M. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003161 · Cited by 629 · see citing works

Targetable genetic features of primary testicular and primary central nervous system lymphomas

Chapuy, B., Roemer, M. G. M., Stewart, C., Tan, Y., Abo, R., Zhang, L., Dunford, A. J., Meredith, D. M., Thorner, A. R., Jordanova, E. S., et al. (2015) · Blood · doi:10.1182/blood-2015-10-673236 · Cited by 579 · see citing works

Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration

Mohamed, T., Ang, Y.-S., Radzinsky, E. M., Zhou, P., Huang, Y., Elfenbein, A., Foley, A., Magnitsky, S. G., & Srivastava, D. (2018) · Cell · doi:10.1016/j.cell.2018.02.014 · Cited by 575 · see citing works

Targeting cell-cycle machinery in cancer

Suski, J. M., Braun, M., Strmiska, V., & Siciński, P. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.03.010 · Cited by 569 · see citing works

Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation

Qi, W., Chan, H., Teng, L., Li, L., Chuai, S., Zhang, R., Zeng, J., Li, M., Fan, H. X., Lin, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210371110 · Cited by 550 · see citing works

Retinoids, Retinoic Acid Receptors, and Cancer

Tang, X.-H., & Gudas, L. J. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130303 · Cited by 596 · see citing works

Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases

Hydbring, P., Malumbres, M., & Sicinski, P. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.27 · Cited by 528 · see citing works

Targeting Mitosis in Cancer: Emerging Strategies

Dominguez-Brauer, C., Thu, K. L., Mason, J. M., Blaser, H., Bray, M. R., & Mak, T. W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.11.006 · Cited by 495 · see citing works

Senescent Cells in Cancer Therapy: Friends or Foes?

Wang, B., Kohli, J., & Demaria, M. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.05.004 · Cited by 508 · see citing works

CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest

Goel, S., DeCristo, M. J., McAllister, S. S., & Zhao, J. J. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.07.002 · Cited by 494 · see citing works

Kinesins and cancer

Rath, O., & Kozielski, F. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3310 · Cited by 497 · see citing works

Targeting CDK4/6 in patients with cancer

Hamilton, E. P., & Infante, J. R. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.03.002 · Cited by 486 · see citing works

Cervical cancer therapies: Current challenges and future perspectives

Burmeister, C. A., Khan, S. F., Schäfer, G., Mbatani, N., Adams, T. S., Moodley, J., & Prince, S. (2022) · Tumour Virus Research · doi:10.1016/j.tvr.2022.200238 · Cited by 512 · see citing works

Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences

Braal, C. L., Jongbloed, E. M., Wilting, S. M., Mathijssen, R. H. J., Koolen, S. L. W., & Jager, A. (2020) · Drugs · doi:10.1007/s40265-020-01461-2 · Cited by 451 · see citing works

Advances in sarcoma genomics and new therapeutic targets

Taylor, B. S., Barretina, J. G., Maki, R. G., Antonescu, C. R., Singer, S., & Ladanyi, M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3087 · Cited by 428 · see citing works

Kinase inhibition in autoimmunity and inflammation

Zarrin, A. A., Bao, K., Lupardus, P., & Vucic, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0082-8 · Cited by 431 · see citing works

An overview of Cdk1-controlled targets and processes

Enserink, J. M., & Kolodner, R. D. (2010) · Cell Division · doi:10.1186/1747-1028-5-11 · Cited by 409 · see citing works

A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma

Puyol, M., Martín, A., Dubus, P., Mulero, F., Pizcueta, P., Khan, G., Guerra, C., Santamaría, D., & Barbacid, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.025 · Cited by 415 · see citing works

Posttranscriptional regulation of cancer traits by HuR

Abdelmohsen, K., & Gorospe, M. (2010) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.4 · Cited by 414 · see citing works

Targeting WEE1 Kinase in Cancer

Matheson, C. J., Backos, D. S., & Reigan, P. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.06.006 · Cited by 414 · see citing works

Kinase-Substrate Enrichment Analysis Provides Insights into the Heterogeneity of Signaling Pathway Activation in Leukemia Cells

Casado, P., Rodríguez‐Prados, J., Cosulich, S. C., Guichard, S. M., Vanhaesebroeck, B., Joel, S., & Cutillas, P. R. (2013) · Science Signaling · doi:10.1126/scisignal.2003573 · Cited by 411 · see citing works

A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?

Cao, X., Ding, L., Xie, Z., Yang, Y., Whiteman, M., Moore, P. K., & Bian, J. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7058 · Cited by 409 · see citing works

Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma

Rader, J., Russell, M. R., Hart, L. S., Nakazawa, M. S., Belcastro, L. T., Martinez, D., Li, Y., Carpenter, E. L., Attiyeh, E. F., Diskin, S. J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1675 · Cited by 394 · see citing works

Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition

Álvarez‐Fernández, M., & Malumbres, M. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.010 · Cited by 395 · see citing works

Fanconi anaemia and cancer: an intricate relationship

Nalepa, G., & Clapp, D. W. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2017.116 · Cited by 388 · see citing works

Inhibitors of cyclin-dependent kinases as cancer therapeutics.

Whittaker, S. R., Mallinger, A., Workman, P., & Clarke, P. A. (2017) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2017.02.008 · Cited by 384 · see citing works

Cell cycle on the crossroad of tumorigenesis and cancer therapy

Liu, J., Peng, Y., & Wei, W. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.07.001 · Cited by 374 · see citing works

Signaling Pathways that Control Cell ProliferationPreprint

Duronio, R. J., & Xiong, Y. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008904 · Cited by 373 · see citing works

Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers

Finn, R. S., Aleshin, A. A., & Slamon, D. J. (2016) · Breast Cancer Research · doi:10.1186/s13058-015-0661-5 · Cited by 379 · see citing works

Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration

Diril, M. K., Ratnacaram, C. K., Padmakumar, V. C., Du, T., Wasser, M., Coppola, V., Tessarollo, L., & Kaldis, P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115201109 · Cited by 385 · see citing works

Targeting cell cycle regulation in cancer therapy

Díaz‐Moralli, S., Tarrado‐Castellarnau, M., Miranda, A., & Cascante, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.011 · Cited by 361 · see citing works

Effect of Nanoparticles on the Cell Life Cycle

Mahmoudi, M., Azadmanesh, K., Shokrgozar, M. A., Journeay, W. S., & Laurent, S. (2011) · Chemical Reviews · doi:10.1021/cr1003166 · Cited by 352 · see citing works

Ten things you should know about protein kinases: IUPHAR R eview 14

Fabbro, D., Cowan‐Jacob, S. W., & Möbitz, H. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13096 · Cited by 350 · see citing works

Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors

Peyressatre, M., Prével, C., Pellerano, M., & Morris, M. C. (2015) · Cancers · doi:10.3390/cancers7010179 · Cited by 345 · see citing works

Nicotine-Mediated Cell Proliferation and Tumor Progression in Smoking-Related Cancers

Schaal, C. M., & Chellappan, S. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0541 · Cited by 347 · see citing works

The Requirement for Cyclin D Function in Tumor Maintenance

Choi, Y. J., Li, X., Hydbring, P., Sanda, T., Stefano, J., Christie, A. L., Signoretti, S., Look, A. T., Kung, A. L., von Boehmer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.015 · Cited by 342 · see citing works

Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer

Quereda, V., Bayle, S., Vena, F., Frydman, S. M., Monastyrskyi, A., Roush, W. R., & Duckett, D. R. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.09.004 · Cited by 352 · see citing works

Targeted protein degradation: advances in drug discovery and clinical practice

Zhong, G., Chang, X., Xie, W., & Zhou, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02004-x · Cited by 326 · see citing works

Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts

Michaud, K., Solomon, D. A., Oermann, E. K., Kim, J.-S., Zhong, W.-Z., Prados, M. D., Ozawa, T., James, C. D., & Waldman, T. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4559 · Cited by 321 · see citing works

A High Proliferation Rate Is Required for Cell Reprogramming and Maintenance of Human Embryonic Stem Cell Identity

Ruiz, S., Panopoulos, A. D., Herrerias, A., Bissig, K., Lutz, M. K., Berggren, W. T., Verma, I. M., & Belmonte, J. C. I. (2010) · Current Biology · doi:10.1016/j.cub.2010.11.049 · Cited by 317 · see citing works

Precision medicine for metastatic breast cancer—limitations and solutions

Arnedos, M., Vicier, C., Loi, S., Lefèbvre, C., Michiels, S., Bonnefoi, H. R., & André, F. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.123 · Cited by 317 · see citing works

Cyclin-dependent protein kinases and cell cycle regulation in biology and disease

Pellarin, I., Dall'Acqua, A., Favero, A., Segatto, I., Rossi, V., Crestan, N., Karimbayli, J., Belletti, B., & Baldassarre, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02080-z · Cited by 323 · see citing works

Assaying Cell Cycle Status Using Flow Cytometry

Kim, K. H., & Sederstrom, J. M. (2015) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb2806s111 · Cited by 311 · see citing works

Mitotic and mitogenic Wnt signalling

Niehrs, C., & Acebron, S. P. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.124 · Cited by 305 · see citing works

DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly

Litovchick, L., Florens, L. A., Swanson, S. K., Washburn, M. P., & DeCaprio, J. A. (2011) · Genes &amp; Development · doi:10.1101/gad.2034211 · Cited by 302 · see citing works

Regulation of cell proliferation by hypoxia-inducible factors

Hubbi, M. E., & Semenza, G. L. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00279.2015 · Cited by 298 · see citing works

High Recovery FASP Applied to the Proteomic Analysis of Microdissected Formalin Fixed Paraffin Embedded Cancer Tissues Retrieves Known Colon Cancer Markers

Wiśniewski, J. R., Ostasiewicz, P., & Mann, M. (2011) · Journal of Proteome Research · doi:10.1021/pr200019m · Cited by 290 · see citing works

Designing a broad-spectrum integrative approach for cancer prevention and treatment

Block, K. I., Gyllenhaal, C., Lowe, L. J., Amedei, A., Amin, A. R. M. R., Amin, A., Aquilano, K., Arbiser, J. L., Arreola, A., Arzumanyan, A. L., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.007 · Cited by 303 · see citing works

Betulin and betulinic acid: triterpenoids derivatives with a powerful biological potential

Hordyjewska, A., Ostapiuk, A., Horecka, A., & Kurzepa, J. (2019) · Phytochemistry Reviews · doi:10.1007/s11101-019-09623-1 · Cited by 299 · see citing works

Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations

Zerdes, I., Matikas, A., Bergh, J. C. S., Rassidakis, G. Z., & Foukakis, T. (2018) · Oncogene · doi:10.1038/s41388-018-0303-3 · Cited by 295 · see citing works

Prognostic relevance of genetic alterations in diffuse lower-grade gliomas

Aoki, K., Nakamura, H., Suzuki, H., Matsuo, K., Kataoka, K., Shimamura, T., Motomura, K., Ohka, F., Shiina, S., Yamamoto, T., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/nox132 · Cited by 307 · see citing works

Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition

Johnson, N., Li, Y., Walton, Z. E., Cheng, K. A., Li, D., Rodig, S. J., Moreau, L. A., Unitt, C., Bronson, R. T., Thomas, H. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2377 · Cited by 290 · see citing works

The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review

Liu, K., Zheng, M., Lu, R., Du, J., Zhao, Q., Li, Z., Li, Y., & Zhang, S. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01304-w · Cited by 289 · see citing works

Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update

Tadesse, S., Caldon, C. E., Tilley, W. D., & Wang, S. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01469 · Cited by 285 · see citing works

Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2

Chen, D., Bohrer, L. R., Rai, A. N., Pan, Y., Gan, L., Zhou, X., Bagchi, A., Simon, J. A., & Huang, H. (2010) · Nature Cell Biology · doi:10.1038/ncb2116 · Cited by 277 · see citing works

Signaling through cyclin D-dependent kinases

Choi, Y., & Anders, L. (2013) · Oncogene · doi:10.1038/onc.2013.137 · Cited by 279 · see citing works

Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen

Bienvenu, F., Jirawatnotai, S., Elias, J. E., Meyer, C. A., Mizeracka, K., Marson, A., Frampton, G. M., Cole, M. F., Odom, D. T., Odajima, J., et al. (2010) · Nature · doi:10.1038/nature08684 · Cited by 276 · see citing works

Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells

de Queiroz, E. A. I. F., Puukila, S., Eichler, R. A. D. S., Sampaio, S. C., Forsyth, H. L., Lees, S. J., Barbosa, A. M., Dekker, R. F. H., Fortes, Z. B., & Khaper, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098207 · Cited by 281 · see citing works

Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability

Fagundes, R., & Teixeira, L. K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.774845 · Cited by 281 · see citing works

The double dealing of cyclin D1

Tchakarska, G., & Sola, B. (2020) · Cell Cycle · doi:10.1080/15384101.2019.1706903 · Cited by 278 · see citing works

MicroRNA dysregulation in gastric cancer: a new player enters the game

Wu, W., Lee, C. W., Chi, H.-C., Fan, D., Wu, K.-C., Yu, J., & Sung, J. J. (2010) · Oncogene · doi:10.1038/onc.2010.352 · Cited by 291 · see citing works

Cell-Cycle Proteins Control Production of Neutrophil Extracellular Traps

Amulic, B., Knackstedt, S. L., Abed, U. A., Deigendesch, N., Harbort, C. J., Caffrey, B. E., Brinkmann, V., Heppner, F. L., Hinds, P. W., & Zychlinsky, A. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.10.013 · Cited by 269 · see citing works

Fueling the Cell Division Cycle

Salazar‐Roa, M., & Malumbres, M. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.08.009 · Cited by 270 · see citing works

Palladium Nanoparticles Induce Disturbances in Cell Cycle Entry and Progression of Peripheral Blood Mononuclear Cells: Paramount Role of Ions

Petrarca, C., Clemente, E., Giampaolo, L. D., Mariani‐Costantini, R., Leopold, K., Schindl, R., Lotti, L. V., Mangifesta, R., Sabbioni, E., Niu, Q. L., et al. (2014) · Journal of Immunology Research · doi:10.1155/2014/295092 · Cited by 266 · see citing works

Integrating Old and New Paradigms of G1/S Control

Rubin, S. M., Sage, J., & Skotheim, J. M. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.08.020 · Cited by 262 · see citing works

Structural insights into the functional diversity of the CDK–cyclin family

Wood, D. J., & Endicott, J. (2018) · Open Biology · doi:10.1098/rsob.180112 · Cited by 264 · see citing works

Targeting signaling pathways in prostate cancer: mechanisms and clinical trials

He, Y., Xu, W., Xiao, Y., Huang, H., Gu, D., & Ren, S. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01042-7 · Cited by 275 · see citing works

AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation

Cianfanelli, V., Fuoco, C., Lorente, M., Salazar‐Roa, M., Quondamatteo, F., Gherardini, P. F., Zio, D. D., Nazio, F., Antonioli, M., D’Orazio, M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3072 · Cited by 258 · see citing works

PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)

He, M., Cao, C., Ni, Z., Liu, Y., Song, P., Hao, S., He, Y., Sun, X., & Rao, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00999-9 · Cited by 283 · see citing works

Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy

Roberts, P. J., Bisi, J. E., Strum, J. C., Combest, A. J., Darr, D. B., Usary, J. E., Zamboni, W. C., Wong, K.-K., Perou, C. M., & Sharpless, N. E. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs002 · Cited by 255 · see citing works

Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes.

Fischer, M., & Müller, G. A. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1360836 · Cited by 255 · see citing works

Ubiquitin Ligases and Cell Cycle Control

Teixeira, L. K., & Reed, S. I. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060410-105307 · Cited by 253 · see citing works

WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe

Hamer, P. C. D. W., Mir, S. E., Noske, D. P., Noorden, C. J. F. V., & Würdinger, T. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2537 · Cited by 252 · see citing works

Investigative progress of relation of CDKs and cancer

Shu-you, Z. (2009) · China Medical Engineering

Cyclins and related kinases in cancer cells.

Malumbres, M. (2007) · PubMed · Cited by 40 · see citing works

Updating the Mammalian Cell Cycle: The Role of Interphase Cdks in Tissue Homeostasis and Cancer

Barbacid, M. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-16602-0_1

Cyclins and CDKS in development and cancer: lessons from genetically modified mice

Santamarı́a, D. (2006) · Frontiers in bioscience · doi:10.2741/1871 · Cited by 164 · see citing works

Cyclin Dependent Kinase as Significant Target for Cancer Treatment

Singh, S. K., Tripathi, S. K., Dessalew, N., & Singh, P. C. (2012) · Current Cancer Therapy Reviews · doi:10.2174/157339412802653164 · Cited by 11 · see citing works